Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
Effect of Canagliflozin Pretreatment on the Efficacy of Insulin Therapy to Rescue Type 1 Diabetes-Related Bone Fragility in Male Mice.
Journal: Calcified tissue international
Published: October 10, 2025
The SGLT2 Inhibitor Canagliflozin Promotes β-Cell Regeneration and Restores and Stabilises β-Cell Identity in a Polygenic Model of Severe Early-Onset Type 2 Diabetes.
Journal: Journal of cellular and molecular medicine
Published: September 13, 2025
Comparison of the association between COVID-19 and new onset diabetes in a regional and national dataset.
Journal: Diabetes research and clinical practice
Published: January 28, 2025
A myostatin inhibitory antibody combined with insulin, partially rescues the musculoskeletal phenotype of female insulin-deficient diabetic mice.
Journal: Frontiers in endocrinology
Published: January 10, 2025
Patterns and Trends in Continuous Glucose Monitoring Utilization Among Commercially Insured Individuals With Type 1 Diabetes: 2010-2013 to 2016-2019.
Journal: Clinical diabetes : a publication of the American Diabetes Association
Published: July 17, 2024
Pharmacologic Inhibition of Myostatin With a Myostatin Antibody Improves the Skeletal Muscle and Bone Phenotype of Male Insulin-Deficient Diabetic Mice.
Journal: JBMR plus
Published: July 01, 2023
Emerging therapies for the treatment of rare pediatric bone disorders.
Journal: Frontiers in pediatrics
Published: August 05, 2022
Mouse models of type 1 diabetes and their use in skeletal research.
Journal: Current opinion in endocrinology, diabetes, and obesity
Published: June 24, 2022
Heterogeneity and altered β-cell identity in the TallyHo model of early-onset type 2 diabetes.
Journal: Acta histochemica
Published: April 10, 2022
Last Updated: 09/26/2026